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Abstract
Background: Optineurin is a multifunctional protein involved in several functions such as vesicular trafficking from
the Golgi to the plasma membrane, NF-B regulation, signal transduction and gene expression. Mutations in
optineurin are associated with glaucoma, a neurodegenerative eye disease that causes blindness. Genetic evidence
suggests that the E50K (Glu50Lys) is a dominant disease-causing mutation of optineurin. However, functional
alterations caused by mutations in optineurin are not known. Here, we have analyzed the role of optineurin in
endocytic recycling and the effect of E50K mutant on this process.
Results: We show that the knockdown of optineurin impairs trafficking of transferrin receptor to the juxtanuclear
region. A point mutation (D474N) in the ubiquitin-binding domain abrogates localization of optineurin to the
recycling endosomes and interaction with transferrin receptor. The function of ubiquitin-binding domain of
optineurin is also needed for trafficking of transferrin to the juxtanuclear region. A disease causing mutation, E50K,
impairs endocytic recycling of transferrin receptor as shown by enlarged recycling endosomes, slower dynamics of
E50K vesicles and decreased transferrin uptake by the E50K-expressing cells. This impaired trafficking by the E50K
mutant requires the function of its ubiquitin-binding domain. Compared to wild type optineurin, the E50K
optineurin shows enhanced interaction and colocalization with transferrin receptor and Rab8. The velocity of Rab8
vesicles is reduced by co-expression of the E50K mutant. These results suggest that the E50K mutant affects Rab8-
mediated transferrin receptor trafficking.
Conclusions: Our results suggest that optineurin regulates endocytic trafficking of transferrin receptor to the
juxtanuclear region. The E50K mutant impairs trafficking at the recycling endosomes due to altered interactions
with Rab8 and transferrin receptor. These results also have implications for the pathogenesis of glaucoma caused
by the E50K mutation because endocytic recycling is vital for maintaining homeostasis.
Background
Optineurin is a multifunctional protein involved in a
variety of functions such as vesicular trafficking from
the Golgi to the plasma membrane, Golgi ribbon forma-
tion, signaling by metabotropic glutamate receptor, reg-
ulation of NF-B activation and gene expression [1-6].
It is a 74 kDa protein that contains multiple coiled-coil
domains, a leucine zipper, a ubiquitin-binding domain
( U B D )a n daC 2 H 2t y p ez i n cf i n g e ra ti t sC - t e r m i n u s
(Figure 1A). Although optineurin is ubiquitously
expressed, it shows high level of expression in certain
tissues such as retina, brain, heart, skeletal muscle, pla-
centa, testis and kidney [7-10]. Studies in various cell
lines have shown that endogenous optineurin is present
in the cytoplasm, Golgi and recycling endosome (RE)
[1,11-14]. However, overexpressed optineurin is present
more prominently in the RE [15].
Some of the optineurin- interacting proteins such as
Rab8, huntingtin and myosinVI are involved in vesicular
trafficking [1,14,16]. Rab8 is a member of family of
small GTPases that regulate intracellular membrane
trafficking pathways [17,18]. It is localized to vesicles at
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fles [16,19-21]. It plays an important role in membrane
trafficking from the TGN to the plasma membrane in
polarized epithelial and neuronal cells, and in membrane
trafficking at the RE [19-24]. Huntingtin, a protein
mutated in the neurodegenerative Huntington’s disease,
is localized to the Golgi complex, and to the endocytic
and exocytic vesicles, where it plays a role in membrane
trafficking pathways [14,25,26]. Myosin VI, an actin
based motor protein, is found in diverse cellular com-
partments including the Golgi complex, membrane ruf-
fles, endocytic vesicles and secretory vesicles [1,13].
Optineurin forms a bridge between myosin VI and Rab8
during sorting of cargo molecules in polarized epithelial
cells [1,13]. Knockdown of optineurin affects Golgi rib-
bon formation and post-Golgi membrane trafficking to
the plasma membrane [1]. However, the role of opti-
neurin in endocytic membrane traffic has not been
examined.
Endocytic membrane traffic is essential for the delivery
of various membrane components, receptors and their
ligands to their respective intracellular compartments
[27]. Transferrin and transferrin receptor (TfR) regulate
iron uptake in almost all cell types, and are frequently
used to study endocytosis and recycling. The iron-
bound transferrin is endocytosed through TfR and deliv-
ered to the peripheral early/sorting endosome [27]. Most
of the internalized TfR is recycled back either through a
fast, direct step from the early endosome, typically with
at 1/2 of 2-3 min, or a slower step via the recycling
endosome, with a t1/2 of ~ 10-15 min. The RE is a net-
work of tubular structures that is perinuclear or juxta-
nuclear in most cells [28-30]. It is a relatively long lived
compartment and acts as a sorting station for the endo-
cytic and exocytic cargo [27]. The transport of cargo
like TfR from the RE to plasma membrane is regulated
by Rab11, whereas Rab8 regulates endocytic traffic to
the RE [21,31-33]. As transport through RE is a rela-
tively slow process, at steady state most of the receptors,
like TfR, that are recycled, are localized mostly at the
endocytic recycling compartment [34].
Mutations in optineurin, encoded by the OPTN gene,
are associated with certain glaucomas, a group of neuro-
degenerative eye diseases that cause blindness [11,35].
However, functional alterations caused by mutations in
optineurin are not known. Genetic evidence suggests
that the E50K (Glu50Lys) is a dominant disease-causing
mutation of optineurin which was found in 13.5% of
families with hereditary glaucoma [11]. Previously we
have analyzed the effect of overexpression of the E50K
and other mutants on survival of various cells [36]. Dur-
ing this work we observed that, as compared to wild
type optineurin, the E50K mutant forms large vesicle-
like structures in many cells. This observation raised the
possibility that the formation of large vesicle-like struc-
tures by the E50K mutant could be due to impaired
trafficking. Here, we have analyzed the role of opti-
neurin in endocytic recycling and the effect of E50K
mutant on this process. Our results show that knock-
down of optineurin results in slower trafficking of TfR
to the juxtanuclear region. We show that optineurin
interacts with TfR and inactivation of the UBD of opti-
neurin by a point mutation abrogates this interaction.
The results of several experiments suggest that the
E50K mutant causes impaired trafficking at the RE due
to enhanced interaction of this mutant with Rab8 and
TfR. The UBD of optineurin plays an essential role in
its localization to the RE and also in impaired trafficking
by the E50K mutant.
Results
Optineurin is required for trafficking of transferrin
receptor
We examined the role of optineurin in trafficking of
TfR, which has served as a model system for the study
of endocytic recycling. For this purpose, two shRNAs
(short hairpin RNAs) which target two different regions
of optineurin mRNA were used to knockdown endogen-
ous optineurin. Infection of HeLa cells with the adeno-
viruses expressing shRNAs (Ad-shOptn1 and Ad-
shOptn2) resulted in 70-80% decrease in optineurin pro-
tein level, as determined by western blotting (Figure 1B).
The level of TfR was unaffected by these shRNAs
(Figure 1B). An adenovirus expressing shRNA of unre-
lated sequence of the same length was used as a control.
HeLa cells were infected with adenoviruses for 72 hours,
serum starved for 2 hours and then incubated with
Alexa546-labeled transferrin. After 15 minutes labeled
transferrin was seen concentrated in the juxtanuclear
region (corresponding to recycling endosomes) in con-
trol cells. Upon knockdown of endogenous optineurin
by two different shRNAs, most of the internalized trans-
ferrin was found distributed throughout the cell espe-
cially in the cell periphery (Figure 1C). The distribution
of endogenous TfR was similar to that of the labeled
transferrin (Figure 1C). Upon chase with unlabeled
transferrin for 30 -45 min, most of the transferrin was
externalized both from the control and optineurin
depleted cells (data not shown). To rule out the possibi-
lity of non-specific effects of shRNA, we generated an
shRNA resistant mutant of optineurin (Figure 1D).
Expression of the shRNA-resistant mutant in knock-
down cells restored the distribution of labeled transfer-
rin to the juxtanuclear region (Figure 1E). These results
suggest that optineurin is required for the trafficking of
TfR to the juxtanuclear region. These results also indi-
cate that in optineurin knockdown cells the sorting
endosomes are taking up most of the TfR or the
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Page 2 of 19Figure 1 Optineurin is required for the trafficking of TfR.( A )S c h e m a t i cr e p r e s e n t a t i o no fo p t i n eurin showing domain organisation, key
mutations and binding sites of interacting proteins. UBD- Ubiquitin Binding Domain (424-511aa), CC-coiled coil domain, ZF- zinc finger domain.
(B) HeLa cells were infected with adenoviruses expressing shRNAs (Ad shOPTN1 and Ad shOPTN2) against optineurin for 72 hrs. Western blots
show levels of endogenous optineurin, TfR and tubulin. (C) HeLa cells were infected with adenoviruses expressing shRNAs for 72 hrs, serum
starved for 2 hrs and then incubated with Alexa-546 conjugated transferrin for 15 min, stained for transferrin receptor and examined by confocal
microscopy. (D) Expression of shRNA resistant mutant of optineurin in HeLa cells. (E) HeLa cells infected with adenoviruses expressing shRNA (Ad
shOPTN2) were transfected with a shRNA resistant mutant of optineurin and were incubated with Alexa 546-Tfn for 15 min. Expression of shRNA
resistant mutant (right panels, shown in green) rescues the effect of shRNA. Bar; 10 μm.
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Page 3 of 19Figure 2 Optineurin is localized to the recycling endosomes. (A) Endogenous optineurin is localized to recycling endosomes in HeLa cells.
HeLa cells were stained sequentially for endogenous optineurin and TfR (upper panel) or were transfected with GFP-Rab11 and stained for
endogenous optineurin (lower panel). Arrows indicate vesicles showing co-localization. (B) HeLa cells were pulsed with Alexa-546 conjugated
transferrin for 30 min, chased with unlabeled holo-transferrin for 20 min and stained for endogenous optineurin. Arrows indicate vesicles
showing colocalization. (C) RGC-5 cells were stained for endogenous optineurin and TfR. (D) E50K mutant optineurin forms large vesicles and co-
localizes with TfR. HeLa cells were transfected with either E50K mutant or wild-type optineurin expressing plasmids lacking a tag and stained
sequentially for optineurin and TfR. E50K mutant optineurin forms large vesicular structures that co-localize strongly with TfR indicated by yellow
colour in the merged image. Right panels show enlarged image of boxed area in merged panels. Bar; 10 μm.
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Page 4 of 19recycling endosome is disrupted spatially or functionally,
or both.
The UBD is required for localization of optineurin to the
recycling endosomes
We examined the localization of endogenous optineurin
in HeLa cells and found that it showed some amount of
colocalization with TfR and Rab11 in some of the vesi-
cles present in the juxtanuclear region (Figure 2A). Both
TfR and Rab11 are markers of RE [27-31,37]. To further
validate these observations, HeLa cells were pulsed with
labeled transferrin for 30 min, chased with unlabelled
transferrin for 20 min and stained for endogenous opti-
neurin. A fraction of endogenous optineurin showed
colocalization with transferrin (Figure 2B). Similarly
endogenous optineurin showed some colocalization with
TfR in RGC-5 cells, a retinal ganglion cell line (Figure
2C). These results showed that at least a small fraction
of endogenous optineurin is present in the recycling
endosomes; this is in addition to its presence in the
Golgi reported previously. Overexpressed optineurin
without tag and its E50K mutant also showed colocaliza-
tion with TfR (Figure. 2D). Vesicles formed by the E50K
Figure 3 The UBD is required for localization of optineurin to RE. (A) HeLa cells were transfected with GFP-tagged wild type optineurin or
its mutants and stained for TfR. Ubiquitin binding defective D474N and E50K-D474N mutants are not recruited to RE as indicated by a lack of
colocalization with TfR. Note the absence of large vesicular structures in E50K-D474N mutant. Bar; 10 μm. (B) The number of vesicles in cells
expressing GFP tagged wild-type and mutant optineurin. (C) Western blot showing expression of GFP tagged optineurin and its mutants, probed
with optineurin antibody. (D) E50K-D474N mutant does not bind ubiquitin. GST-ubiquitin or GST alone bound to glutathione agarose beads
were incubated with lysates of HeLa cells transfected with wild type optineurin or its mutants. The bound proteins were eluted and
immunoblotted with anti-HA antibodies. WCL, 5% whole cell lysate.
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Page 5 of 19mutant showed better colocalization with TfR compared
to vesicles formed by wild type optineurin (correlation
coefficient, E50K mutant 0.59 ± 0.11, wild type opti-
neurin 0.29 ± 0.07; p < 0.05) (Figure 2D). The E50K
mutant expressed without tag (Figure 2D) or with GFP
tag (Figure 3A) formed larger vesicle-like structures
than wild type optineurin mostly in the juxtanuclear
region (Table 1). The cells expressing E50K mutant
showed larger number of vesicle-like structures than
those expressing wild type optineurin (Figure 3B). For-
mation of larger vesicle-like structures by GFP-E50K
was not due to its higher level of expression as com-
pared to GFP-optineurin (Figure 3C). We then analyzed
colocalization of overexpressed optineurin and its E50K
mutant with markers of early endosome (EEA1), late
endosome (Rab7) and trans-Golgi network (TGN46).
Overexpressed optineurin and the E50K mutant did not
show any significant colocalization with EEA1, although
few vesicles showed colocalization with Rab7 and
TGN46 (Figure 4A-C). However, both E50K mutant and
wild type optineurin showed significant colocalization
with Rab11 (correlation coefficient, E50K mutant 0.45 ±
0.08, wild type optineurin 0.32 ± 0.04) (Figure 5). These
results suggest that most of the E50K vesicles are not
likely to be routed to late endosome or lysosome
although a small fraction might be doing so.
A recent study showed the presence of a novel UBD
in optineurin, and the D474N mutation in this UBD
abolished the binding of optineurin to ubiquitinated
proteins [3]. To explore the role of the UBD in the
recruitment of E50K mutant to recycling endosomes, we
generated the D474N mutant and a double mutant of
optineurin that contains both E50K and D474N muta-
tions (Figure 1A). The D474N mutant formed smaller
and fewer vesicle-like structures than those formed by
wild type optineurin (Table 1 and Figure 3B). The
D474N mutant showed very little colocalization with
TfR (correlation coefficient, D474N mutant 0.10 ± 0.03,
wild type optineurin 0.38 ± 0.11) (Figure 3A) or Rab11
(Figure 5). The E50K-D474N double mutant also formed
few small vesicle-like structures similar to D474N
mutant, and did not show any significant colocalization
with TfR (correlation coefficient, double mutant 0.08 ±
0.04, E50K mutant 0.58 ± 0.10) (Table 1; Figure 3A and
3B) or Rab11 (Figure 5). We then examined the ability
of optineurin and E50K mutant to bind ubiquitin in an
in vitro assay. Lysates of HeLa cells transfected with
wild type optineurin or E50K or E50K-D474N mutants
were incubated with GST-ubiquitin and bound proteins
were analyzed by Western blot. As compared to wild
type optineurin, E50K mutant showed a marginal
increase in binding with GST-ubiquitin (Figure 3D). The
E50K-D474N double mutant did not show any binding
to GST-ubiquitin (Figure 3D). These results suggest that
the UBD plays an essential role in the localization of
optineurin and its E50K mutant to the RE and in the
formation of large vesicle-like structures by E50K
mutant.
The UBD of optineurin is required for trafficking of
transferrin to the juxtranuclear region
Since UBD was required for localization of optineurin to
the RE, we examined its role in trafficking of labeled
transferrin to the RE. For this purpose we generated
shRNA-resistant D474N mutant of optineurin. While
re-introduction of shRNA resistant wild-type optineurin
could restore distribution of transferrin to the juxtanuc-
lear region, in cells expressing shRNA resistant D474N
mutant, transferrin was found distributed throughout
the cell (Figure 6). These observations suggest that a
functional UBD is required for trafficking of transferrin
to the juxtanuclear region.
The E50K mutant causes reduced uptake of transferrin
We examined the effect of over expressed optineurin
and E50K mutant on trafficking of transferrin. HeLa
cells transfected with either wild-type or E50K opti-
neurin were incubated with Alexa594-conjugated trans-
ferrin. To our surprise the uptake of transferrin was
significantly reduced in majority of the cells expressing
mutant optineurin (Figure 7A). Quantitative analysis
showed that there was 60% inhibition (P < 0.001) of
uptake of labeled transferrin by mutant optineurin,
whereas wild type optineurin showed no significant inhi-
bition (Figure. 7B). The reduction in uptake of transfer-
rin was not due to decreased level of total cellular TfR
in E50K expressing cells (Figure 7C). However, the
amount of cell surface associated TfR in the E50K
expressing cells was decreased (Figure 7D), suggesting
that the reduced uptake of transferrin by the E50K
expressing cells was due to a reduction in TfR on the
cell surface. The expression of either D474N mutant or
double mutant E50K-D474N did not cause any reduc-
tion in the uptake of labeled transferrin (Figure 7A, B),
indicating therefore that the interactions of UBD are
required for the effect of E50K on transferrin uptake.
Neither the steady state localization of TfR nor traffick-
ing of transferrin was affected by overexpression of
D474N or E50K-D474N mutant suggesting that these
mutants possibly do not affect the function of endogen-
ous optineurin. The formation of transferrin receptor-
Table 1 Sizes of vesicles formed by optineurin and its
mutants
Vesicles formed by Size in μm
Wild-type optineurin 0.79 ± 0.18
E50K 1.38 ± 0.43
D474N 0.51 ± 0.15
E50K-D474N 0.58 ± 0.16
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Page 6 of 19positive large vesicles by the E50K mutant and the
decreased uptake of transferrin, suggest that the E50K
optineurin causes a reduction in endocytic recycling of
transferrin receptor, leading to its accumulation in the
large vesicular structures.
The E50K mutant exhibits slower dynamics
The dynamics of the optineurin-containing vesicles was
analyzed using time-lapse video microscopy. GFP-tagged
wild type or E50K optineurin cDNAs were transfected
into HeLa cells and the vesicle movement monitored by
acquiring a series of time lapse images (Figure 8A and
Additional files 1 and 2). A large number of these vesi-
cles moved inwards from the cell periphery towards the
nucleus/Golgi body (though a few moved outward).
Occasional fusing of the smaller vesicles with larger
ones was observed, mainly in the perinuclear region.
Analysis of velocities of vesicles of largely comparable
sizes revealed that wild type optineurin vesicles moved
at an average velocity of 3.9 ± 0.4 μm/min, while those
containing the mutant moved significantly slower (2.2 ±
Figure 4 Characterization of subcellular localization of optineurin and E50K mutant. HeLa cells were transfected with HA-tagged wild type
or E50K mutant optineurin and stained for (A) an early endosome marker EEA1 or (B) TGN46, a marker for trans-Golgi or (C) co-transfected with
GFP-Rab7, a marker for late endosome.
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Page 7 of 190.36 μm/min) (p < 0.001) (Figure 8B). The E50K-D474N
containing vesicles moved at an average velocity of 4.72
±0 . 4 2μm/min. We then determined the pausing of
vesicles by measuring the time these vesicles spend
without moving and found that E50K vesicles paused
for a longer period of time compared with wild type
optineurin vesicles (Figure 8C).
Fluorescence recovery after photo bleaching (FRAP) is
a widely used method to measure two dimensional dif-
fusion of molecules in live cells. We further analyzed
the dynamics of E50K mutant and wild-type optineurin
in the vesicles of comparable size by using FRAP. These
experiments showed that the half time of recovery of
fluorescence in the E50K-containing vesicles was higher
(t 1/2 = 7.13 ± 1.865 secs) than those with the wild type
molecule (t 1/2 = 1.68 ± 0.489 secs; P < 0.01) (Figure
8D).
Optineurin interacts with transferrin receptor through
UBD
The results so far showed that optineurin is required for
TfR trafficking and it is localized to the recycling endo-
s o m e st h r o u g hi t sU B D .H o wd o e st h eU B Dh e l pi n
recruitment or retention of optineurin in the recycling
endosomes? One possibility is that optineurin may form
a complex with a ubiquitinated protein present in the
recycling endosomes. Since optineurin colocalizes with
Figure 5 Colocalization of optineurin and E50K mutant with Rab11. HeLa cells were co-transfected with HA-tagged wildtype optineurin or
its mutants and GFP-Rab11. Both wildtype optineurin and E50K mutant show colocalization with Rab11. Insets show enlarged region of the
boxed area. Correlation coefficients for co-localization, wild-type optineurin, 0.32 ± 0.04; E50K, 0.45 ± 0.08; D474N, 0.07 ± 0.03; E50K-D474N, 0.08
± 0.04.
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Page 8 of 19TfR very well, we examined the possibility of complex
formation between optineurin and TfR. To analyze the
interaction between endogenous optineurin and TfR,
HeLa cell lysates were immunoprecipitated with opti-
neurin antibody. TfR was detected in the immunopreci-
pitate with optineurin antibody but not with control
antibody (Figure 9A). To examine the possible role of
the UBD of optineurin in complex formation with TfR,
we used the D474N mutant which does not bind ubiqui-
tin. HeLa cells were transfected with either HA-tagged
wild-type or D474N mutant optineurin and immunopre-
cipitation was carried out with HA antibody. While TfR
was detected in the immunoprecipitate from wild type
optineurin expressing cells, inactivation of the UBD
resulted in 80% reduction of complex formation
between optineurin and TfR (Figure 9B). Since the inter-
action between optineurin and TfR was dependent on
intact UBD, it raised an interesting possibility that TfR
complexed with optineurin could be ubiquitinated.
Reprobing of the blot with ubiquitin antibody suggested
that TfR, that was complexed with overexpressed opti-
neurin, was ubiquitinated( F i g u r e9 B ) .T op r o v i d e
further evidence for ubiquitination of TfR, we immuno-
precipitated it from optineurin-overexpressing and con-
trol cells. Western blot of the immunoprecipitate with
ubiquitin antibody showed a band moving slower than
t h eb u l ko ft h ei m m u n o p r e c i p itated TfR, comigrating
with the upper band of TfR in optineurin-overexpres-
sing cells (Figure 9C). In the control cells we could not
detect ubiquitinated TfR. These results suggest that ubi-
quitination of TfR is transient and overexpression of
optineurin enhances this ubiquitination.
The E50K mutant shows enhanced interaction with
transferrin receptor
We compared the ability of optineurin and its E50K
mutant to form complex with TfR by immunoprecipita-
tion. In the E50K immunoprecipitate, 7 fold higher level of
TfR was present compared to the optineurin
immunoprecipitate, as determined by Western blot (Figure
10A). The role of the UBD in complex formation between
E50K and TfR was examined by using E50K-D474N dou-
ble mutant which showed a drastic reduction in complex
formation with TfR (Figure 10B). Reprobing of this blot
with ubiquitin antibody suggested that the TfR immuno-
precipitated by E50K is ubiquitinated (Figure 10B). Vesi-
cles formed by the E50K mutant and wild type optineurin
showed colocalization with endogenous ubiquitin (Figure
10C). The double mutant E50K-D474N formed very few
small vesicles which did not show significant colocaliza-
tion with ubiquitin (Figure 10C). Staining for transferrin
receptor in the cells co-transfected with HA-ubiquitin and
wild-type or E50K mutant optineurin showed that ubiqui-
tin colocalizes with both E50K mutant and transferrin
receptor in same vesicular structures (Figure 10D). These
results suggest that optineurin and the E50K mutant are
recruited to the RE (or retained in the RE) by complex for-
mation with a ubiquitinated protein, possibly TfR. These
results also indicate that formation of larger vesicles (RE)
by E50K might be due to formation of stronger complex
with TfR.
The E50K mutant is altered in its interaction with Rab8
Rab GTPases control various membrane trafficking
pathways in the cell and Rab8 is involved in regulating
exocytic and recycling membrane trafficking at the RE
[20-24]. Optineurin interacts directly with the constitu-
tively active GTP bound Q67L-Rab8 mutant but not
inactive T22N mutant [16]. It is therefore believed that
optineurin is an effector of some of the functions of
Rab8. Rab8 is also required for the trafficking of TfR to
the juxtanuclear region [21]. We next tested the hypoth-
esis, that the E50K mutant of optineurin might be
altered in its interaction with Rab8, by immunoprecipi-
tation experiments. HeLa cells were cotransfected with
Myc-tagged Q67L-Rab8 mutant and wild-type or E50K
mutant optineurin. Immunoprecipitation experiments
revealed that in the Rab8 immunoprecipitate 2.9 fold
Figure 6 The UBD is required for trafficking of transferrin. HeLa cells infected with adenoviruses expressing shRNA (Ad-shOPTN2) were
transfected with shRNA resistant wild type or D474N mutant optineurin. Cells were incubated with Alexa 546-Tfn for 15 min, fixed, stained for
optineurin and examined by confocal microscopy.
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Page 9 of 19Figure 7 The E50K mutant causes reduced uptake of transferrin. (A) HeLa cells were transfected with GFP- tagged wild type optineurin or
its mutants, serum starved and incubated with Alexa-594 conjugated transferrin for 20 min. Cells were then fixed and observed with a confocal
microscope. (B) The uptake of labelled transferrin was quantitated by measuring the fluorescence intensity in expressing (filled bar) and non-
expressing (empty bar) cells. (C) Western blot showing expression of TfR in cells infected with adenoviruses expressing wild-type or E50K mutant
optineurin or control viruses. Western blot shows levels of TfR, optineurin and tubulin. (D) HeLa cells were transfected with GFP-tagged wild-type
or E50K mutant optineurin. TfR present at the plasma membrane was visualized by staining these cells without permeablilzation using TfR
antibody.
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type optineurin (Figure 11A). This suggests that as com-
pared with optineurin, E50K forms a stronger complex
with Q67L-Rab8. Transferrin receptor was also seen in
Rab8 immunoprecipitates co-expressing optineurin or
E50K mutant (Figure 11A). Quantitative analysis of the
western blot showed that the amount of TfR was 96%
more in Rab8 immunoprecipitate from the E50K expres-
sing cells compared to wild type optineurin expressing
cells. In accordance with these observations, the E50K
mutant showed better colocalization with Q67L-Rab8
compared to wild type optineurin (correlation coeffi-
cient, E50K mutant 0.63 ± 0.12, wild type optineurin
0.28 ± 0.04; p < 0.01) (Figure 11B). We then examined
the distribution of TfR in cells co-expressing E50K and
Q67L-Rab8. Both the TfR and Rab8 (Q67L) were found
together in the same vesicular structures as that of
E50K but to a lesser extent in cells containing wild type
optineurin (Figure 11B). Quantitative analysis of pair
wise colocalization was carried out by calculating
Figure 8 The E50K mutant exhibits slower dynamics. (A) Dynamics of optineurin and E50K mutant vesicles. Individual frames from a movie
of cells transfected with GFP-optineurin (upper panels) or GFP-E50K (lower panels) with the images acquired every 12 secs. Frame sequence
illustrates the movement of a vesicle (denoted by an arrow). Additional files 1 and 2 show the movement of these vesicles. Bar; 5 μm. (B)
Velocities of wild type and E50K mutant optineurin vesicles. E50K vesicles move significantly slower compared to wild type optineurin. (C)
Pausing time of GFP-optineurin and GFP-E50K vesicles. (D) HeLa cells were transfected with GFP-tagged E50K or wild type optineurin. A
representative fluorescence recovery curve after photobleaching is shown. Right panel shows t1/2 time for E50K and optineurin.
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Page 11 of 19correlation coefficients (Table 2). This analysis suggests
that Rab8 shows better colocalization with TfR in the
E50K-expressing cells compared to wild type optineurin
expressing cells. These observations provide support to
our results showing that compared to wild type opti-
neurin, the E50K mutant shows stronger interaction
with Rab8 and TfR. Taken together these results suggest
that optineurin associates with Rab8 and TfR through
its different domains to form a trimolecular complex.
In order to ascertain if the E50K mutant affects Rab8
function, we examined the dynamics of Rab8 vesicles in
the presence of E50K mutant and wild type optineurin
by time-lapse video microscopy. HeLa cells were
cotransfected with GFP-Rab8 and HA-optineurin or
E50K mutant or GFP-Rab8 alone. The movement of
Rab8 vesicles was then monitored by acquiring a series
of time-lapse images. Rab8 formed mostly elongated
tubular structures with many smaller, rapidly moving
vesicles. These Rab8 vesicles moved at an average velo-
city of 6.84 ± 1.38 μm/min. Co-expression of wild type
optineurin only slightly reduced the velocity of Rab8
vesicles (5.83 ± 0.408 μm/min). In the cells co-expres-
sing E50K, Rab8 formed conspicuous vesicles whose
velocity was decreased to 2.64 ± 0.25 μm/min (P <
0.001) (Figure 11C). These results suggest that the E50K
mutant optineurin affects trafficking of Rab8.
The UBD is required for induction of cell death by the
E50K mutant in RGC5 cells
Defective vision in glaucoma occurs due to apoptotic
death of RGCs in the optic nerve head [35]. We have
shown earlier that the E50K mutant of optineurin selec-
tively induces the death of RGCs, and not of other cell
lines tested [36], indicating that this mutation causes
glaucoma by directly inducing the death of RGCs. To
explore the role of the UBD of E50K in inducing death
of RGCs, we studied the effect of the E50K-D474N dou-
b l em u t a n to nR G C 5c e l l s ,a n df o u n dt h a ti td i dn o t
induce cell death (Figure 12A). In RGC5 cells also, the
E50K mutant showed strong colocalization with TfR
whereas the E50K-D474N mutant showed much less
colocalization (correlation coefficient, E50K mutant 0.59
± 0.09, double mutant 0.12 ± 0.09, wild type optineurin,
0.41 ± 0.11; p < 0.05) (Figure 12B). Expression of the
E50K mutant in RGC5 cells reduced the uptake of
transferrin whereas the double mutant did not (Figure
12C). These results show that the function of UBD is
required for the retinal ganglion cell death induced by
the E50K mutant of optineurin.
Discussion
Optineurin gene is mutated in certain forms of glau-
coma. The E50K mutation is the most common and
severe disease causing mutation [11,38]. Nevertheless,
the nature of functional alterations caused by mutations
in optineurin and their probable role in etiopathogensis
of glaucoma are unclear. Here we have investigated the
role of optineurin in endocytic trafficking of TfR and
how the E50K mutant affects this trafficking. Our results
show that optineurin regulates trafficking of TfR to the
juxtanuclear region and at least a fraction of endogen-
ous as well as overexpressed optineurin is localized to
the RE. This localization of optineurin to the RE is
dependent on a functional UBD. The results of several
independent experiments suggest that the E50K mutant
causes impaired trafficking at the RE; these include: (a)
E50K forms larger, TfR-containing vesicles (RE) than
those formed by normal optineurin, (b) E50K vesicles
Figure 9 Optineurin interacts with TfR through UBD.( A )
Endogenous optineurin interacts with endogenous TfR. Endogenous
optineurin was immunoprecipitated from HeLa cells using anti-
optineurin or control antibody. Immunoprecipitates were resolved in
SDS-PAGE and subjected to Western blotting with TfR and
optineurin antibodies. (B) UBD of optineurin is essential for
interaction with TfR. HeLa cells were transfected with HA-optineurin
or HA-D474N mutant optineurin. After 30 hrs of transfection, lysates
were immunoprecipitated with anti-HA or control antibody and
subjected to Western blotting with TfR, ubiquitin and HA antibodies.
(C) TfR was immunoprecipitated from optineurin-overexpressing and
control cells. Western blot of the immunoprecipitate was done with
ubiquitin, TfR and optineurin antibodies. WCL, 5% whole cell lysate.
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Page 12 of 19show slower velocity and pause more frequently than
those formed by normal optineurin, (c) the expression
of E50K mutant (but not normal optineurin) reduces
uptake of labeled transferrin by the cells, and (d) the
expression of E50K reduces velocity of Rab8 vesicles.
A recent study has shown the presence of a novel
UBD in optineurin through which it binds Lys63 linked
poly-ubiquitin chains [3]. The ubiquitin binding-defi-
cient mutants of optineurin and its E50K mutant failed
to localize to the RE and did not form complex with
TfR. These results suggest that the function of UBD is
required for the localization of optineurin to the RE.
The function of UBD is also needed for trafficking of
transferrin to the juxtranuclear region because shRNA
resistant D474N mutant could not rescue the effect of
optineurin knockdown. Thus we have identified novel
f u n c t i o n so ft h eU B Do fo p t i n e u r i n .S i n c eo p t i n e u r i n
interacts with TfR through UBD, it is likely that this
interaction plays a role in the localization of optineurin
to the RE.
Figure 10 The E50K mutant shows enhanced interaction with TfR. (A) E50K mutant shows enhanced interaction with TfR. HeLa cells were
transfected with HA-tagged E50K mutant or wild type optineurin. After 30 hrs of transfection, lysates were prepared and immunoprecipitated
with HA or control antibody and subjected to Western blotting with TfR, ubiquitin and HA antibodies. WCL, 5% whole cell lysate. (B) Interaction
of E50K mutant optineurin with TfR is mediated through UBD. HeLa cells were transfected with HA-tagged E50K mutant or E50K-D474N mutant
optineurin and immunoprecipitation was carried out as described in (A). WCL, 5% whole cell lysate. (C) E50K mutant colocalizes with ubiquitin.
HeLa cells were transfected with GFP-tagged constructs of wild-type optineurin or its mutants and stained for endogenous ubiquitin. (D) E50K
mutant colocalizes with ubiquitin in recycling endosomes. HeLa cells were co-transfected with GFP-tagged constructs of wild-type optineurin or
E50K and HA-ubiquitin and stained with TfR and HA antibodies.
Nagabhushana et al. BMC Cell Biology 2010, 11:4
http://www.biomedcentral.com/1471-2121/11/4
Page 13 of 19Figure 11 The E50K mutant is altered in its interaction with Rab8. (A) E50K mutant shows enhanced interaction with activated Rab8. HeLa
cells were infected with adenoviruses expressing HA-E50K or HA-optineurin and then transfected with Myc-Q67L-Rab8 mutant. After 36 hrs of
infection, lysates were prepared and immunoprecipitated with anti-Myc or control antibody and subjected to Western blotting with TfR, HA and
anti-Myc antibodies. WCL, 5% whole cell lysate. (B) Co-localization of E50K mutant with Q67L-Rab8 and TfR. HeLa cells were cotransfected with
GFP-tagged Q67L-Rab8 along with HA- tagged E50K mutant or wild type optineurin. Cells were stained sequentially with antibodies against HA-
tag (red) and transferrin receptor (blue). Pairwise colocalizations are shown as indicated. Bar; 10 μm. (C) E50K mutant affects velocity of Rab8
vesicles. HeLa cells were co-transfected with HA-E50K or HA-optineurin and GFP-Rab8 and the movement of Rab8 vesicles was tracked to
measure their velocities. In cells co-expressing E50K velocity of Rab8 vesicles is reduced compared to those expressing wild type optineurin or
Rab8 alone.
Table 2 Correlation coefficients for pairwise colocalization
Cells expressing Colocalization/Proteins compared Correlation coefficient
Wild-type optineurin and Q67L Rab8 Optineurin and Q67L-Rab8 0.29 ± 0.02*
Q67L-Rab8 and TfR 0.42 ± 0.09**
Optineurin and TfR 0.28 ± 0.03***
E50K mutant and Q67L-Rab8 E50K and Q67L-Rab8 0.63 ± 0.12*
Q67L-Rab8 and TfR 0.58 ± 0.06**
E50K and TfR 0.58 ± 0.07***
*p < 0.01; **p < 0.05; ***p < 0.01
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Page 14 of 19Figure 12 The induction of cell death in RGC-5 cells by E50K mutant requires the UBD. (A) RGC-5 cells were transfected with wild type
optineurin or E50K mutant or their UBD mutants and percentage of cells undergoing cell death were quantified in transfected and
untransfected cells. Data represent mean ± SD of 3 independent experiments. (B) E50K mutant colocalizes with TfR in RGC5 cells. GFP-tagged
optineurin or its mutants were transfected in RGC-5 cells and stained for TfR. E50K mutant optineurin forms large vesicular structures that co-
localize strongly with TfR indicated by yellow colour in the merged image. (C). E50K mutant causes reduced uptake of transferrin in RGC-5 cells.
RGC-5 cells were transfected with GFP- tagged wildtype optineurin or its mutants and incubated with Alexa-546 conjugated transferrin for 20
min. Cells were then fixed and observed with a confocal microscope. The uptake of labelled transferrin was quantitated by measuring the
fluorescence intensity in expressing (filled bar) and non-expressing (empty bar) cells. Bar; 10 μm.
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Page 15 of 19Ubiquitination plays a key role in various aspects of
vesicular trafficking, including internalization and the
endocytosis of many cell surface receptors [39,40]. Ubi-
quitination of endocytosed receptors usually serves as a
targeting signal for lysosome for their eventual degrada-
tion. The role of ubiquitination in endocytic recycling is
uncertain. Our results indicate that TfR that is com-
plexed with optineurin and the E50K mutant is ubiquiti-
nated. It has been observed that TfR when tagged to
ubiquitin is targeted to lysosomes [41]. Our observations
provide first indication of the ubiquitination of TfR at
the RE. However, this ubiquitination of TfR is likely to
be very transient. Recently it has been shown that opti-
neurin enhances ubiquitination of Tax1 protein of
HTLV-1 raising the possibility that optineurin may be
involved in regulating ubiquitination [42]. It is plausible
that the overexperssed wild-type optineurin and its
E50K mutant in particular either enhance this ubiquiti-
nation, or by their stronger association/affinity for ubi-
quitinated TfR, might prevent it’s deubiquitination.
However, the role of ubiquitination of TfR in its recy-
cling needs further investigation. It is probable that the
ubiquitination of TfR may be involved in the localization
of optineurin to the RE.
Various studies have shown a role for Rab8 in traffick-
ing at the recycling endosomes [20,21,23]. Interestingly,
cells depleted of Rab8 are also defective in trafficking of
TfR and exhibit a similar phenotype as that of opti-
neurin depleted cells (this paper) implicating that both
Rab8 and optineurin may regulate a common pathway
in the trafficking of TfR [21]. Since optineurin interacts
directly with Rab8, we suggest that optineurin, Rab8 and
TfR form a trimolecular complex and recruit additional
factors to facilitate transferrin/TfR trafficking to the RE.
Stronger association and colocalization of Rab8 and TfR
in presence of the E50K mutant suggest that the E50K
mutant affects Rab8 mediated TfR trafficking. This sug-
gestion is supported by the observation that the E50K
mutant reduces the velocity of Rab8 vesicles.
Yue and colleagues have shown that in two ocular cell
lines most of the endogenous optineurin is not present in
the Golgi and overexpessed optineurin forms foci which
co-localize with markers of the recycling endosomes [15].
The E50K mutant forms larger and more foci, and induces
more cell death in retinal pigmented epithelial cells. It was
speculated that the Golgi breakdown and/or defect in vesi-
cle trafficking may be involved in the induction of cell
death by the E50K mutant. Whether defective trafficking
caused by the E50K mutant contributes to the Golgi
breakdown is yet to be investigated.
E50K is a dominantly inherited mutation which shows
strong association with glaucoma phenotype in a large
family, suggesting therefore that it is a disease causing
mutation [11]. The E50K mutant but not wild type
optineurin causes death of RGC, indicating thereby that
this mutation causes glaucoma by directly inducing death
of RGC [36]. Since optineurin does not have any enzy-
matic activity it is likely that the altered interactions (direct
or indirect) of the E50K mutant with cellular proteins
might cause functional defects leading to RGC death. The
E50K mutant shows enhanced interaction with a protein
kinase, TBK1, although functional significance of this
interaction is not known [43]. Here, we have shown that
the E50K mutant causes impaired endocytic recycling of
TfR, and altered interactions of this mutant with Rab8 and
TfR possibly contribute to impaired trafficking. Impaired
trafficking by the E50K mutant is likely to affect cellular
homeostasis because constant recycling of receptors
between the cell membrane and RE is vital for maintaining
homeostasis of membrane components and nutrients,
such as iron. Endocytic recycling also plays an important
role in cellular signal transduction by many cell surface
receptors [44,45]. Requirement of the UBD for impaired
trafficking as well as induction of cell death in RGC by the
E50K mutant indicates that the impaired trafficking caused
by E50K might contribute to death of RGC, possibly by
disrupting cellular homeostasis or signal transduction.
Patients with mutations in optineurin, such as E50K,
have glaucoma and are not affected in other tissues
although optineurin is expressed ubiquitously. It is likely
that mutations in optineurin affect a function that is cri-
tical for the survival of neuronal cells. Some studies
have shown blockade of axonal transport in glaucoma-
tous conditions [46-48]. Axonal transport, especially of
neurotrophins, is essential for the survival of neuronal
cells including RGCs. Since E50K mutant impairs endo-
cytic recycling, it is likely that this mutant causes defec-
tive axonal trafficking. The higher levels of optineurin in
RGCs compared to brain might contribute to increased
RGC death resulting in glaucoma with relatively little or
no neuronal cell death elsewhere.
Conclusions
Our results show that optineurin is required for trafficking
of transferrin receptor to the juxtanuclear region. Opti-
neurin is localized to the RE through UBD, which is also
required for trafficking of TfR to the juxtanuclear region.
Dynamic interactions of optineurin with Rab8 and TfR are
likely to contribute to the endocytic recycling of TfR. A
disease causing mutation, E50K, impairs endocytic recy-
cling of TfR, possibly due to altered interactions with Rab8
and TfR. These results also have implications for the
pathogenesis of glaucoma caused by the E50K mutation.
Methods
cDNA constructs and reagents
Plasmid vectors for expressing human optineurin and its
mutants (E50K) with HA tag have been described [36].
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GFP- tag. Optineurin and E50K mutant without tag
were produced by cloning the required cDNA in
pcDNA3 plasmid. Human Rab7 and Rab11 were PCR
amplified from A549 cell RNA and cloned in pEGFP-
C3. Human ubiquitin cDNA was amplified by PCR and
cloned in pGEX4T3 vector. Point mutations in opti-
neurin and Rab8 were created by a PCR based site
directed mutagenesis strategy. A mutant of optineurin
resistant to degradation by shOPTN2 was generated by
mutating four nucleotides in the region targeted for
degradation by shOPTN2 without changing the amino
acid sequence of the optineurin protein.
Mouse monoclonal anti-ubiquitin was from Calbio-
chem, rabbit polyclonal anti-optineurin was from
Abcam, mouse monoclonal anti-transferrin receptor was
from Zymed. mouse monoclonal anti-HA was from
Roche Applied Biosystems. Rabbit polyclonal anti-HA
was from SantaCruz, Alexa 546-conjugated transferrin
was from Molecular Probes.
Cell Culture and transfections
Retinal ganglion cell line RGC-5 has been described pre-
viously [49,50]. HeLa and RGC-5 cells were maintained
at 37°C in a CO2 incubator as described [36]. Transfec-
tions were done using Lipofectamine Plus™ reagent
(Invitrogen Life Technologies, Inc.) according to the
manufacturer’s instructions.
Indirect immunofluorescence and confocal microscopy
For immunofluorescence, cells grown on coverslips were
transfected with required plasmids, fixed and stained
with appropriate antibodies, as described previously
[51]. For analysis of co-localization cells were observed
using a LSM 510 Meta or LSM 510 NLO confocal
microscopes (Carl Zeiss Microimaging, Jena). For ima-
ging GFP and cy3, a 488 nm argon laser and 543 nm or
561 nm DPSS laser was used. Serial optical sections in
the Z-axis of the cells were collected at 0.33 μmi n t e r -
vals with a 63 × oil immersion objective lens (NA 1.4).
Generally 2 serial optic sections were projected and
colocalization was observed using LSM 510 (version 3.2)
software. Quantitative analysis of colocalization was car-
ried out by calculating Pearson’s correlation coefficients
using LSM 510 software. Sizes of about 120 vesicles
from 10 different cells expressing wild type and mutant
optineurin were estimated using LSM 510 (version 3.2)
software. Images were further processed with Adobe
Photoshop software. The number of vesicles (larger than
0.5 μm and 0.8 μm) in wild-type and mutant optineurin
expressing cells was computed in at least 100 cells using
Imaris software (Bitplane scientific solutions).
Generation of adenoviral vectors
Endogenous optineurin was down-regulated by using
adenoviral vectors expressing shRNAs as described pre-
viously using pAdEASY system [4,52,53].
Adenoviral vectors for expressing optineurin and its
E50K mutant were prepared as described using
pAdEASY system [4,53].
Immunoprecipitation and GST pull down
Immunoprecipitations were carried as essentially as
described [51]. The proteins were eluted by boiling in 3
× SDS sample buffer and resolved by SDS-PAGE. The
proteins were transferred to nitrocellulose membrane
for western blot analysis as described [54].
For GST pull down assays, GST, GST-ubiquitin were
expressed in E. coli and were conjugated to Sepharose
beads as described [55]. GST- or GST-ubiquitin beads
were incubated 6-8 hours with lysates of HeLa cells
transiently transfected with indicated plasmids. Bound
proteins were eluted by boiling in 3 × SDS sample buf-
fer and subjected to immunoblotting.
Time-lapse microscopy
HeLa cells were plated on chambered coverglass (Lab-
Tek) and transfected with appropriate GFP-tagged con-
structs. Cells expressing GFP tagged constructs were
observed with a Zeiss LSM 5 Live confocal microscope.
GFP was excited by using a 488 nm diode laser and
images were acquired at an interval of 12 secs or 5 secs
using a 63 × oil or 100× oil immersion objectives (NA
1.4). During the imaging cells were maintained at 37°C
and 5% CO2. The movement of the vesicles were
tracked by using Metamorph software (Universal ima-
ging). For calculating the velocities, 200 vesicles (~4800
measurements) in 12 E50K expressing cells and 160
vesicles (~2800 measurements) in 11 OPTN expressing
cells were tracked. For calculating pausing, the total
amount of time a vesicle remains stationary was deter-
mined and is expressed as a percentage [56]. A vesicle
was considered to be stationary or paused, if the displa-
cement is 1 pixel or less for at least 3 consecutive time
points.
Transferrin Uptake
After 24 hrs of transfections, HeLa cells grown on cov-
erslips were washed and pre-incubated with serum free
DMEM for 2 hrs. Cells were then incubated with 10 μg/
ml of Alexa594 conjugated transferrin (Molecular
Probes) in serum-free medium for 1 hr at 4°C. Cells
were then shifted to 37°C for 25 min to label recycling
endosomes, washed with PBS twice and fixed in 3.7%
formaldehyde. For quantitative analysis, the fluorescence
intensity of internalized transferrin was measured using
ImageJ software (n = 180 cells for E50K, n = 160 cells
for wild type optineurin). The fluorescence intensities of
the transfected cells were normalized with non-expres-
sing cells.
Frap
HeLa cells grown in chambered coverglass were trans-
fected with required plasmids. Photobleaching experi-
ments were carried out using LSM510 NLO microscope.
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For bleaching, cells transfected with 250 ng of each
EGFP-containing construct were excited with a 488 nm
laser. Bleaching was carried out by selecting circular
regions of interest of diameter 2 μm, using 100% of
laser power with the pinhole kept at 2 airy units. To
determine the rate of fluorescence recovery, fluorescence
i nt h e s er e g i o n sw a sm e a s u r e do v e rt i m eb ya c q u i r i n g
images at low laser power (0.6%) every 400 msecs for 3
min, and then normalised with respect to corresponding
total cellular fluorescence at each individual time point
to correct for bleaching during low power laser
excitation.
Cell Death Assays
Quantitative analysis of dead or apoptotic cells was car-
ried out as described [36,57].
Statistical analysis
Graphs represent average ± SD values. Statistical differ-
ences were calculated using Student’s T-test. When sig-
nificant differences were observed, P values for pair wise
comparisons were calculated by using two-tailed T-test.
P values less than 0.05 were considered significant.
Additional file 1: Dynamics of vesicles formed by GFP-optineurin.
HeLa cell transfected with GFP-OPTN was imaged by time lapse video
microscope. Images were acquired every 12 sec for 15 min and played at
5 frames per second. Movie shows the movement of vesicles. Bar, 5 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-4-
S1.MOV]
Additional file 2: Dynamics of vesicles formed by GFP-E50K. Images
were acquired every 12 sec for 15 min and played at 5 frames per
second. Movie shows the movement of vesicles with occasional fusion of
smaller vesicles with larger vesicles in the perinuclear region. Bar, 5 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2121-11-4-
S2.MOV]
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